DuPont Nutrition & Health, FrieslandCampina Domo, Abbott and Ingredion Are Dominating the Market for Global Oligosaccharides in Infant Nutrition Market in 2017

Global Oligosaccharides In Infant Nutrition Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Access Full Report:

The global oligosaccharides in infant nutrition market highly concentrated to a few big players and rest to local players who cater to domestic markets only. DuPont Nutrition & Health dominated the oligosaccharides in infant nutrition market accounting for a highest market share in 2017, followed by FrieslandCampina Domo, Abbott and Ingredion. Other players in this market include are Carbosynth, Dairy Crest, Dextra Laboratories Limited, Elicityl SA, Inbiose NV, Jennewein Biotechnologie GmbH, Tereos, ZuChem among others.

DuPont Nutrition & Health:

DuPont Nutrition & Health, founded in 1989 and based in Denmark, engaged in manufacturing ingredients for food, beverage, pharmaceutical and dietary supplements industries. It offers wide range of food & beverages products by the brand, Danisco. It offers HMOs for infant nutrition. It operates as a subsidiary of DowDuPont.

  • In March 2018, Inbiose (Belgium) and DuPont Nutrition & Health (DuPont) (Denmark) received EU regulatory approval and licensing agreement for the exclusive rights to produce and commercialize 2’-FL and other selected fucosylated HMOs for food applications in the European market..

FrieslandCampina Domo:

FrieslandCampina Domo, founded in 2009 and based in Netherlands. It is involved in manufacturing of ingredients, base powders and total formulas for the infant and toddler markets and ingredients for the medical and cell nutrition markets. It offers wide range of galaoctooligosaccharides product for infant nutrition.

The company operates as a subsidiary of FrieslandCampina. It has its presence in Europe, Asia and Oceania, Africa and the Middle East, North and South America.

  • In Feburary 2016, FrieslandCampina (Netherland) and Glycosyn (U.S.) partnered for the development of the next generation infant nutrition. This has strengthened the company’s position as a market leader in infant nutrition ingredients.




Abbott, founded in 1888 and headquarters in Illinois, U.S., focuses on manufacturing products for diagnostics, medical devices, nutrition and branded generic pharmaceuticals. It operates its business through Established Pharmaceuticals, Nutritionals, Diagnostics, Cardiovascular and Neuromodulation and Others. It offers HMOs prebiotics for infant nutrition through its Nutritional segment.

The company has its presence in U.S., China, Germany, Japan, India, The Netherland, Switzerland, Russia, France, Brazil, Italy, U.K., Colombia, Canada, Vietnam and others. It has its subsidiaries worldwide such as Alere Inc. (U.S.), Abbott Medical Optics Inc. (U.S.), EAS (U.S.), Abbott India Ltd(India), Thoratec Corporation(U.S.) and others.

  • In October 2018, Abbott (U.S.) launched CDMX product in Mexico. It contains HMOs (Human Milk Oligosaccharides).The purpose of this product is to support the immune and digestive health of child. This development has increased company’s reach in the region.